Empagliflozin vs Montelukast

Empagliflozin vs Montelukast: Overview

This comparison examines the pharmacological differences between Empagliflozin and Montelukast.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Montelukast — C35H36ClNO3S.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Montelukast — 586.1800 g/mol.

Type: Empagliflozin — Small molecule; Montelukast — Small molecule.